Freedom of Health Speech Act

H. Res. 98, expressing the sense of the House that the commissioner of the Food and Drug Administration should give the greatest weight in making critical policy decisions to readily available hard science data, including evidence from the natural sciences, physical sciences, and computing sciences. H.R. 1364, to amend the Federal Food, Drug, and Cosmetic Act concerning the distribution of information on legitimate scientific research in connection with foods and dietary supplements, and for other purposes. H.R. 1382, to require the president to call a White House conference on food and nutrition. H.R. 2044, to amend the Federal Food, Drug, and Cosmetic Act concerning claims about the effects of foods and dietary supplements on health-related conditions and disease, and for other purposes; to Energy & Commerce. H.R.2045, to amend the Federal Trade Commission Act concerning the burden of proof in false advertising cases involving dietary supplements and dietary ingredients. H.R. 3214, to amend the Food and Drug Administration's mission; to Energy & Commerce. S. 216, to increase criminal penalties for certain knowing and international violations relating to food that is misbranded or adulterated; to Judiciary. S. 1581, to improve the importer of record program and the collection of fees and duties in connection with the importation of merchandise into the United States, and for other purposes; to Finance. S. 1662, to amend the Federal Food, Drug, and Cosmetic Act to establish a nanotechnology regulatory science program; to Health, Education, Labor, & Pensions.

Client expense: $110,000 · Firm income: Not reported

Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE

Viral Hepatitis and Liver Cancer Control and Prevention Act of 2010, all provisions. H.R. 2045, Pandemic and All-Hazards Preparedness Reauthorization Act of 2011. S. 3187, the Food and Drug Administration Safety and Innovation Act. S. 2113, Transforming the Regulatory Environment to Accelerate Access to Treatments.

Client expense: Not reported · Firm income: $60,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R.2045, Freedom of Health Speech Act, Dietary supplement issues.

Client expense: Not reported · Firm income: $25,000

Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE

H.R.2045, Freedom of Health Speech Act, Dietary supplement issues.

Client expense: Not reported · Firm income: $30,000

Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE

H.R.2045, Freedom of Health Speech Act, Dietary supplement issues.

Client expense: Not reported · Firm income: $14,400

Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE

H. Res. 98, expressing the sense of the House that the commissioner of the Food and Drug Administration should give the greatest weight in making critical policy decisions to readily available hard science data, including evidence from the natural sciences, physical sciences, and computing sciences. H.R. 1364, to amend the Federal Food, Drug, and Cosmetic Act concerning the distribution of information on legitimate scientific research in connection with foods and dietary supplements, and for other purposes. H.R. 1382, to require the president to call a White House conference on food and nutrition; to Agriculture. H.R. 2044, to amend the Federal Food, Drug, and Cosmetic Act concerning claims about the effects of foods and dietary supplements on health-related conditions and disease, and for other purposes; to Energy & Commerce. H.R.2045, to amend the Federal Trade Commission Act concerning the burden of proof in false advertising cases involving dietary supplements and dietary ingredients. H.R.2045, to amend the Federal Trade Commission Act concerning the burden of proof in false advertising cases involving dietary supplements and dietary ingredients. H.R. 3214, to amend the Food and Drug Administration's mission; to Energy & Commerce. S. 216, to increase criminal penalties for certain knowing and international violations relating to food that is misbranded or adulterated. S. 1581, to improve the importer of record program and the collection of fees and duties in connection with the importation of merchandise into the United States, and for other purposes. S. 1662, to amend the Federal Food, Drug, and Cosmetic Act to establish a nanotechnology regulatory science program.

Client expense: $110,000 · Firm income: Not reported

Issues related to raising awareness of Hepatitis C. Viral Hepatitis and Liver Cancer Control and Prevention Act of 2010, all provisions. H.R. 2045, Pandemic and All-Hazards Preparedness Reauthorization Act of 2011. S. 3187, the Food and Drug Administration Safety and Innovation Act. S. 2113, Transforming the Regulatory Environment to Accelerate Access to Treatments.

Client expense: Not reported · Firm income: $60,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R.2045, Freedom of Health Speech Act, Dietary supplement issues.

Client expense: Not reported · Firm income: $20,000

Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE

H. Res. 98, expressing the sense of the House that the commissioner of the Food and Drug Administration should give the greatest weight in making critical policy decisions to readily available hard science data, including evidence from the natural sciences, physical sciences, and computing sciences. H.R. 1364, to amend the Federal Food, Drug, and Cosmetic Act concerning the distribution of information on legitimate scientific research in connection with foods and dietary supplements, and for other purposes. H.R. 1382, to require the president to call a White House conference on food and nutrition; to Agriculture. H.R. 2044, to amend the Federal Food, Drug, and Cosmetic Act concerning claims about the effects of foods and dietary supplements on health-related conditions and disease, and for other purposes; to Energy & Commerce. H.R.2045, to amend the Federal Trade Commission Act concerning the burden of proof in false advertising cases involving dietary supplements and dietary ingredients. H.R.2045, to amend the Federal Trade Commission Act concerning the burden of proof in false advertising cases involving dietary supplements and dietary ingredients. H.R. 3214, to amend the Food and Drug Administration's mission; to Energy & Commerce. S. 216, to increase criminal penalties for certain knowing and international violations relating to food that is misbranded or adulterated. S. 1581, to improve the importer of record program and the collection of fees and duties in connection with the importation of merchandise into the United States, and for other purposes. S. 1662, to amend the Federal Food, Drug, and Cosmetic Act to establish a nanotechnology regulatory science program.

Client expense: $110,000 · Firm income: Not reported

Issues related to raising awareness of Hepatitis C. Viral Hepatitis and Liver Cancer Control and Prevention Act of 2010, all provisions. H.R. 2045, Pandemic and All-Hazards Preparedness Reauthorization Act of 2011. Reauthorization of the Prescription Drug User Fee Act.

Client expense: Not reported · Firm income: Not reported

Government targets: SENATE

Issues related to raising awareness of Hepatitis C. Viral Hepatitis and Liver Cancer Control and Prevention Act of 2010, all provisions. H.R. 2045, Pandemic and All-Hazards Preparedness Reauthorization Act of 2011. Reauthorization of the Prescription Drug User Fee Act. S. 2113, Transforming the Regulatory Environment to Accelerate Access to Treatments.

Client expense: Not reported · Firm income: $60,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R.2045, Freedom of Health Speech Act, Dietary supplement issues.

Client expense: Not reported · Firm income: $14,400

Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE

H.R.2045, Freedom of Health Speech Act, Dietary supplement issues.

Client expense: Not reported · Firm income: $10,000

Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE

S. 216 - Food Safety Accountability Act, a bill to increase criminal penalties for certain knowing and intentional violations relating to food that is misbranded or adulterated; all provisions relating to dietary supplements H.R. 1364 - Free Speech About Science Act, a bill to amend the FD&CA concerning the distribution of information on legitimate scientific research in connection with foods and dietary supplements; all provisions relating to dietary supplements S. 1310 - Dietary Supplement Labeling Act, a bill to improve the safety of dietary supplements by amending the Federal Food, Drug, and Cosmetic Act to require manufacturers of dietary supplements to register dietary supplement products with the Food and Drug Administration and to amend labeling requirements with respect to dietary supplements H.R. 2044 - Health Freedom Act, a bill to amend the Federal Food, Drug, and Cosmetic Act concerning claims about the effects of foods and dietary supplements on health-related conditions and disease, and for other purposes H.R. 2045 - Freedom of Health Speech Act, a bill to amend the Federal Trade Commission Act concerning the burden of proof in false advertising cases involving dietary supplements and dietary ingredients HR 2736 - Access to Medical Treatment Act, a bill to permit an individual to be treated by a health care practitioner with any method of medical treatment such individual requests, and for other purposes; all provisions relating to dietary supplements HR 2908 - Testimonial Free Speech Act, a bill to protect the First Amendment rights of individuals to share their experiences and perceptions of the effects of foods and dietary supplements HR 3204 - Guidance Accountability and Transparency Act, a bill to amend the Federal Food, Drug, and Cosmetic Act to ensure public participation in the drafting and issuance of Level 1 guidance documents, and for other purposes; all provisions relating to dietary supplements HR 3214 - Food and Drug Administration Mission Reform Act, a bill to amend the Food and Drug Administration's mission; all provisions relating to dietary supplements HR 3380 - Dietary Supplement Protection Act, a bill to amend the Federal Food, Drug, and Cosmetic Act concerning safe dietary ingredients in dietary supplements New Dietary Ingredient Notification Guidance - Docket No. FDA-2011-D-0376, CFSAN 20117. Draft Guidance for Industry; Dietary Supplements: New Dietary Ingredient Notifications and Related Issues

S. 216 - Food Safety Accountability Act, a bill to increase criminal penalties for certain knowing and intentional violations relating to food that is misbranded or adulterated; all provisions relating to dietary supplements H.R. 1364 - Free Speech About Science Act, a bill to amend the FD&CA concerning the distribution of information on legitimate scientific research in connection with foods and dietary supplements; all provisions relating to dietary supplements S. 1310 - Dietary Supplement Labeling Act, a bill to improve the safety of dietary supplements by amending the Federal Food, Drug, and Cosmetic Act to require manufacturers of dietary supplements to register dietary supplement products with the Food and Drug Administration and to amend labeling requirements with respect to dietary supplements H.R. 2044 - Health Freedom Act, a bill to amend the Federal Food, Drug, and Cosmetic Act concerning claims about the effects of foods and dietary supplements on health-related conditions and disease, and for other purposes H.R. 2045 - Freedom of Health Speech Act, a bill to amend the Federal Trade Commission Act concerning the burden of proof in false advertising cases involving dietary supplements and dietary ingredients HR 2736 - Access to Medical Treatment Act, a bill to permit an individual to be treated by a health care practitioner with any method of medical treatment such individual requests, and for other purposes; all provisions relating to dietary supplements HR 2908 - Testimonial Free Speech Act, a bill to protect the First Amendment rights of individuals to share their experiences and perceptions of the effects of foods and dietary supplements HR 3204 - Guidance Accountability and Transparency Act, a bill to amend the Federal Food, Drug, and Cosmetic Act to ensure public participation in the drafting and issuance of Level 1 guidance documents, and for other purposes; all provisions relating to dietary supplements HR 3214 - Food and Drug Administration Mission Reform Act, a bill to amend the Food and Drug Administration's mission; all provisions relating to dietary supplements HR 3380 - Dietary Supplement Protection Act, a bill to amend the Federal Food, Drug, and Cosmetic Act concerning safe dietary ingredients in dietary supplements New Dietary Ingredient Notification Guidance - Docket No. FDA-2011-D-0376, CFSAN 20117. Draft Guidance for Industry; Dietary Supplements: New Dietary Ingredient Notifications and Related Issues

H. Res. 98, expressing the sense of the House that the commissioner of the Food and Drug Administration should give the greatest weight in making critical policy decisions to readily available hard science data, including evidence from the natural sciences, physical sciences, and computing sciences. H.R. 1364, to amend the Federal Food, Drug, and Cosmetic Act concerning the distribution of information on legitimate scientific research in connection with foods and dietary supplements, and for other purposes. H.R. 1382, to require the president to call a White House conference on food and nutrition; to Agriculture. H.R. 2044, to amend the Federal Food, Drug, and Cosmetic Act concerning claims about the effects of foods and dietary supplements on health-related conditions and disease, and for other purposes; to Energy & Commerce. H.R.2045, to amend the Federal Trade Commission Act concerning the burden of proof in false advertising cases involving dietary supplements and dietary ingredients. H.R.2045, to amend the Federal Trade Commission Act concerning the burden of proof in false advertising cases involving dietary supplements and dietary ingredients. S. 216, to increase criminal penalties for certain knowing and international violations relating to food that is misbranded or adulterated. S. 1581, to improve the importer of record program and the collection of fees and duties in connection with the importation of merchandise into the United States, and for other purposes. S. 1662, to amend the Federal Food, Drug, and Cosmetic Act to establish a nanotechnology regulatory science program.

Client expense: $110,000 · Firm income: Not reported

Issues related to raising awareness of Hepatitis C. Viral Hepatitis and Liver Cancer Control and Prevention Act of 2010, all provisions. FY 2012 Labor/HHS/Education Appropriations, provisions related to viral hepatitis funding. H.R. 2045, Pandemic and All-Hazards Preparedness Reauthorization Act of 2011. Reauthorization of the Prescription Drug User Fee Act.

Client expense: Not reported · Firm income: $60,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R.2045, Freedom of Health Speech Act, Dietary supplement issues.

Client expense: Not reported · Firm income: $20,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R.2045, Freedom of Health Speech Act, Dietary supplement issues. Public Law 111-296, Healthy, Hunger-Free Kids Act of 2010, Implementation issues regarding Nutrition H.R.2112, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations S.1599, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations, FY2012

Client expense: Not reported · Firm income: $14,400

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Issues related to raising awareness of Hepatitis C. Viral Hepatitis and Liver Cancer Control and Prevention Act of 2010, all provisions. FY 2012 Labor/HHS/Education Appropriations, provisions related to viral hepatitis funding. H.R. 2045, Pandemic and All-Hazards Preparedness Reauthorization Act of 2011.

Client expense: Not reported · Firm income: $60,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H. Res. 98, expressing the sense of the House that the commissioner of the Food and Drug Administration should give the greatest weight in making critical policy decisions to readily available hard science data, including evidence from the natural sciences, physical sciences, and computing sciences. H.R. 1364, to amend the Federal Food, Drug, and Cosmetic Act concerning the distribution of information on legitimate scientific research in connection with foods and dietary supplements, and for other purposes. H.R. 1382, to require the president to call a White House conference on food and nutrition; to Agriculture. H.R. 2044, to amend the Federal Food, Drug, and Cosmetic Act concerning claims about the effects of foods and dietary supplements on health-related conditions and disease, and for other purposes; to Energy & Commerce. H.R.2045, to amend the Federal Trade Commission Act concerning the burden of proof in false advertising cases involving dietary supplements and dietary ingredients. H.R.2045, to amend the Federal Trade Commission Act concerning the burden of proof in false advertising cases involving dietary supplements and dietary ingredients. S. 216, to increase criminal penalties for certain knowing and international violations relating to food that is misbranded or adulterated. S. 1581, to improve the importer of record program and the collection of fees and duties in connection with the importation of merchandise into the United States, and for other purposes. S. 1662, to amend the Federal Food, Drug, and Cosmetic Act to establish a nanotechnology regulatory science program.

Client expense: $110,000 · Firm income: Not reported

S. 216 - Food Safety Accountability Act, a bill to increase criminal penalties for certain knowing and intentional violations relating to food that is misbranded or adulterated; all provisions relating to dietary supplements H.R. 1364 - Free Speech About Science Act, a bill to amend the FDCA concerning the distribution of information on legitimate scientific research in connection with foods and dietary supplements; all provisions relating to dietary supplements H.R. 2044 - Health Freedom Act, a bill to amend the Federal Food, Drug, and Cosmetic Act concerning claims about the effects of foods and dietary supplements on health-related conditions and disease, and for other purposes H.R. 2045 - Freedom of Health Speech Act, a bill to amend the Federal Trade Commission Act concerning the burden of proof in false advertising cases involving dietary supplements and dietary ingredients S. 1310 - Dietary Supplement Labeling Act, a bill to improve the safety of dietary supplements by amending the Federal Food, Drug, and Cosmetic Act to require manufacturers of dietary supplements to register dietary supplement products with the Food and Drug Administration and to amend labeling requirements with respect to dietary supplements HR 2736 - Access to Medical Treatment Act, a bill to permit an individual to be treated by a health care practitioner with any method of medical treatment such individual requests, and for other purposes; all provisions relating to dietary supplements HR 2908 - Testimonial Free Speech Act, a bill to protect the First Amendment rights of individuals to share their experiences and perceptions of the effects of foods and dietary supplements. New Dietary Ingredient Notification Guidance - Docket No. FDA-2011-D-0376, CFSAN 20117. Draft Guidance for Industry; Dietary Supplements: New Dietary Ingredient Notifications and Related Issues

H.R.2045, Freedom of Health Speech Act, Dietary supplement issues.

Client expense: Not reported · Firm income: $10,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H. Res. 98, expressing the sense of the House that the commissioner of the Food and Drug Administration should give the greatest weight in making critical policy decisions to readily available hard science data, including evidence from the natural sciences, physical sciences, and computing sciences. H.R. 1364, to amend the Federal Food, Drug, and Cosmetic Act concerning the distribution of information on legitimate scientific research in connection with foods and dietary supplements, and for other purposes. H.R. 1382, to require the president to call a White House conference on food and nutrition; to Agriculture. H.R. 2044, to amend the Federal Food, Drug, and Cosmetic Act concerning claims about the effects of foods and dietary supplements on health-related conditions and disease, and for other purposes; to Energy & Commerce. H.R.2045, to amend the Federal Trade Commission Act concerning the burden of proof in false advertising cases involving dietary supplements and dietary ingredients. S. 216, to increase criminal penalties for certain knowing and international violations relating to food that is misbranded or adulterated.

Client expense: $110,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE, Treasury, Dept of, U.S. Trade Representative (USTR)

H.R.2045, Freedom of Health Speech Act, Dietary supplement issues.

Client expense: Not reported · Firm income: $14,400

Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE

H.R.2045, Freedom of Health Speech Act, Dietary supplement issues.

Client expense: Not reported · Firm income: $20,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

S. 216 - Food Safety Accountability Act, a bill to increase criminal penalties for certain knowing and intentional violations relating to food that is misbranded or adulterated; all provisions relating to dietary supplements H.R. 1364 - Free Speech About Science Act, a bill to amend the FDCA concerning the distribution of information on legitimate scientific research in connection with foods and dietary supplements; all provisions relating to dietary supplements H.R. 2044 - Health Freedom Act, a bill to amend the Federal Food, Drug, and Cosmetic Act concerning claims about the effects of foods and dietary supplements on health-related conditions and disease, and for other purposes H.R. 2045 - Freedom of Health Speech Act, a bill to amend the Federal Trade Commission Act concerning the burden of proof in false advertising cases involving dietary supplements and dietary ingredients S. 1310 - Dietary Supplement Labeling Act, a bill to improve the safety of dietary supplements by amending the Federal Food, Drug, and Cosmetic Act to require manufacturers of dietary supplements to register dietary supplement products with the Food and Drug Administration and to amend labeling requirements with respect to dietary supplements New Dietary Ingredient Notification Guidance - Docket No. FDA-2011-D-0376, CFSAN 20117. Draft Guidance for Industry; Dietary Supplements: New Dietary Ingredient Notifications and Related Issues

Client expense: $140,000 · Firm income: Not reported